// App-Quantinova.ai

: Benefits of tiotropium/olodaterol compared with tiotropium in patients with COPD receiving only LAMA at baseline: pooled analysis of 4 clinical trials

Researchers

Presenter

  • Roland Buhl

Principal Investigators

  • Dave Singh

  • Alberto De La Hoz

  • Florian Vo

  • Gary T. Ferguson

Medical Centers

  • Johannes-Gutenberg Universitat Mainz, Mainz, Germany

  • Medicines Evaluation Unit, University Hospital of South Manchester NHS Foundation Trust, University of Manchester, Manchester, United Kingdom,

  • Boehringer Ingelheim International GmbH, Ingelheim am Rhein, Germany,

  • Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim Am Rhein, Germany

  • Pulmonary Research Institute of Southeast Michigan, Farmingtin Hills, MI, United States.

Locations

  • Germany

  • United Kingdom

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

Disease

  • Chronic obstructive pulmonary disease

Biomarkers

  • N/A

Drug/Treatment

  • Tiotropium/olodaterol

Outcome

  • N/A

Study Design

  • N/A

Phase

  • III

Study Id's

  • NCT01431287

  • NCT02006732

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved